Related Experiment Videos

[Low molecular weight oligosaccharides active in plasma against factor Xa (author's transl)]

J Choay, J C Lormeau, M Petitou

Annales Pharmaceutiques Francaises

|May 1, 1981

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Neutralization of EP217609, a new dual-action FIIa/FXa anticoagulant, by its specific antidote avidin: a phase I study.

European journal of clinical pharmacology·2016

First in man study of EP217609, a new long-acting, neutralisable parenteral antithrombotic with a dual mechanism of action.

European journal of clinical pharmacology·2016

Synthesis, radiolabeling with fluorine-18 and preliminary in vivo evaluation of a heparan sulphate mimetic as potent angiogenesis and heparanase inhibitor for cancer applications.

Organic & biomolecular chemistry·2016

EP42675, a synthetic parenteral dual-action anticoagulant: pharmacokinetics, pharmacodynamics, and absence of interactions with antiplatelet drugs.

Journal of thrombosis and haemostasis : JTH·2013

Reversible biotinylated oligosaccharides: a new approach for a better management of anticoagulant therapy.

Journal of thrombosis and haemostasis : JTH·2008

Comparative effects of two synthetic oligosaccharides on platelet activation induced by plasma from HIT patients.

Journal of thrombosis and haemostasis : JTH·2003

See all related articles